Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medworxx Announces Appropriate Length of Stay Audit Offering

C.RGX
Medworxx Announces Appropriate Length of Stay Audit Offering

Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today is pleased to announce a new program, the Appropriate Length of Stay Audit, that helps to unlock unique patient flow data which helps organizations understand patient flow issues.

The Appropriate Length of Stay Audit (“ALSA”) uses the proven Medworxx software as an audit and diagnostic solution, prior to hospitals implementing the solution operationally. Management consulting companies and hospital support agencies are able to use Medworxx to rapidly unlock unique patient flow data, providing visibility into patient flow issues in the hospitals that they provide services to.

“In working with Medworxx to conduct several audits this year, we have found that the patient flow data provided by the Medworxx solution provides visibility into patient flow issues and challenges in the hospitals we are working with,” says Anita Grindlay, Director, EQ Health (Australia). “Without the Medworxx solution, this data would be nearly impossible to gather.”

With the Appropriate Length of Stay Audit program, consulting companies and healthcare support organizations have the ability to license the Medworxx solution to provide them with patient flow data and assist them in their analysis. In addition Medworxx provides training and consulting expertise to consultants in their use of the Medworxx Patient Flow platform.

“The ALSA program is an effective solution for consulting companies to expand their practices by providing insight into patient flow issues that without Medworxx would be extremely difficult to gather. It also allows hospitals to get exposure to the Medworxx solution, which we believe will fuel their desire to have this data every day, and therefore license the product after the audit process,” said Dan Matlow, CEO & President, Medworxx. “We have been pilot marketing the ALSA program to consulting companies internationally and the reception has been very positive. We are now ready to be extremely active in this approach; the ALSA program is becoming a key component of our go to market strategy for our patient flow platform.”

The Medworxx solution has been successfully used in audits in the United Kingdom together with our partner Model Advice. Current Medworxx clients Royal Liverpool and Broadgreen University Hospitals NHS Trust and South Tees Hospitals NHS Trust started off as diagnostic audits and later licensed the platform for operational use. Medworxx has completed 6 additional audits internationally in 2013 with various organizations as part of our pilot process.

About Medworxx
Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Clinical Criteria—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves 33%of the acute care beds in Canada.

Visit: http://www.medworxx.com/

Disclaimer
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.

<div class="copyright"> Copyright Business Wire 2013 </div>


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today